These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4420227)

  • 41. [One of the complications of steroid therapy: posterior subcapsular cataract].
    Lama G; Fusco G; Norma A; Iuliano P; Iuglio N
    Pediatria (Napoli); 1983; 91(2-3):205-10. PubMed ID: 6664729
    [No Abstract]   [Full Text] [Related]  

  • 42. Factors influencing the development of steroid-induced myopathies.
    Faludi G; Gotlieb J; Meyers J
    Ann N Y Acad Sci; 1966 Sep; 138(1):62-72. PubMed ID: 5230216
    [No Abstract]   [Full Text] [Related]  

  • 43. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
    Mishra OP; Abhinay A; Mishra RN; Prasad R; Pohl M
    J Trop Pediatr; 2013 Oct; 59(5):343-9. PubMed ID: 23619602
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Difficult-to-treat nephrotic syndrome: management and outcome.
    Sumboonnanonda A; Chongchate N; Suntornpoch V; Pattaragarn A; Supavekin S
    J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S142-8. PubMed ID: 16856434
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Results of the treatment of steroid-resistant and steroid-dependent nephrotic syndrome with pulsed doses of prednisolone].
    Gura C; Pałka L; Pańczyk-Tomaszewska M; Sieniawska M; Pazdur J
    Wiad Lek; 1992 May; 45(9-10):343-8. PubMed ID: 1441541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Posterior subcapsular cataracts in corticosteroid-treated children.
    Braver DA; Richards RD; Good TA
    J Pediatr; 1966 Nov; 69(5):735-8. PubMed ID: 5928005
    [No Abstract]   [Full Text] [Related]  

  • 47. [Use of cyclophosphamide and corticoids in the treatment of nephrotic syndrome: controlled study].
    Rocha H; Vaccaro Torres CE; Lessa I; Azevêdo Vinhaes L
    Rev Bras Pesqui Med Biol; 1972; 5(1-2):21-8. PubMed ID: 4680451
    [No Abstract]   [Full Text] [Related]  

  • 48. [Steroid therapy for nephrotic syndrome--indications and methods of administration].
    Koide K; Toyama J; Uwadoko S; Nagase M
    Nihon Rinsho; 1979 Jun; 37(6):1295-301. PubMed ID: 480656
    [No Abstract]   [Full Text] [Related]  

  • 49. The idiopathic nephrotic syndrome of childhood. A clinical reevaluation of 148 cases.
    Makker SP; Heymann W
    Am J Dis Child; 1974 Jun; 127(6):830-7. PubMed ID: 4834775
    [No Abstract]   [Full Text] [Related]  

  • 50. Behavioural abnormalities in children with nephrotic syndrome.
    Mishra OP; Basu B; Upadhyay SK; Prasad R; Schaefer F
    Nephrol Dial Transplant; 2010 Aug; 25(8):2537-41. PubMed ID: 20200003
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of alternate-day steroid therapy for nephrotic syndrome in childhood by cross-over study.
    Yamashita F; Funatsu T; Nagayama K; Arihiro H; Anan S
    Kurume Med J; 1971; 18(3):153-60. PubMed ID: 4944762
    [No Abstract]   [Full Text] [Related]  

  • 52. A new dose schedule of corticosteroids in nephrotic syndrome in infancy and childhood.
    Dikshit SK; Katiyar GP
    Indian J Med Res; 1971 Nov; 59(11):1779-87. PubMed ID: 5143168
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative study of prednisolone alone and prednisolone plus fusidic acid in the treatment of children with steroid-responsive nephrotic syndrome.
    Cerkauskiene R; Kaltenis P
    Medicina (Kaunas); 2005; 41 Suppl 1():26-30. PubMed ID: 15901972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corticosteroids and cataracts.
    Spaeth GL; Von Sallmann L
    Int Ophthalmol Clin; 1966; 6(4):915-28. PubMed ID: 4865222
    [No Abstract]   [Full Text] [Related]  

  • 55. Adrenocortical suppression increases the risk of relapse in nephrotic syndrome.
    Abeyagunawardena AS; Hindmarsh P; Trompeter RS
    Arch Dis Child; 2007 Jul; 92(7):585-8. PubMed ID: 17284479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is renal biopsy necessary in the management of the nephrotic syndrome?
    Mani MK
    J Assoc Physicians India; 1989 Dec; 37(12):752-4. PubMed ID: 2519640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of the effectiveness of bolus doses of prednisolone in steroid-resistant and steroid-dependent nephrotic syndrome in children].
    Kryński J; Wyszyńska T
    Pediatr Pol; 1985 Feb; 60(2):163-8. PubMed ID: 3895148
    [No Abstract]   [Full Text] [Related]  

  • 58. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
    Mishra OP; Thakur N; Mishra RN; Prasad R
    J Nephrol; 2012; 25(3):394-400. PubMed ID: 21928226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nephrotic syndrome caused by membranous nephropathy: response to a short course of cyclophosphamide alternating with prednisolone.
    Fujimoto S; Hara S; Sato Y; Yamada K; Hisanaga S; Eto T
    Intern Med; 2004 Jan; 43(1):30-4. PubMed ID: 14964576
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intermittent versus long-term tapering prednisolone for initial therapy in children with idiopathic nephrotic syndrome.
    Ueda N; Chihara M; Kawaguchi S; Niinomi Y; Nonoda T; Matsumoto J; Ohnishi M; Yasaki T
    J Pediatr; 1988 Jan; 112(1):122-6. PubMed ID: 3335948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.